Skip to main content
DBVT
NASDAQ Life Sciences

Bpifrance Group Exits 13D Reporting, Reduces Stake Below 5%

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
7
Price
$17.99
Mkt Cap
$704.884M
52W Low
$3.303
52W High
$26.185
Market data snapshot near publication time

summarizeSummary

An institutional investor group, led by Bpifrance Participations, has filed its final Schedule 13D amendment, indicating their beneficial ownership in DBV Technologies S.A. has dropped below 5%.


check_boxKey Events

  • Institutional Investor Group Reduces Stake

    Bpifrance Participations and its affiliated entities, a significant institutional investor group, have reduced their beneficial ownership in DBV Technologies S.A. through recent open market sales.

  • Below 5% Reporting Threshold

    The group's aggregate beneficial ownership has fallen below 5% of the outstanding Ordinary Shares, which means they are no longer required to file Schedule 13D reports.

  • Final Schedule 13D Amendment

    This filing represents the tenth and final amendment to their Schedule 13D, indicating a complete exit from their active reporting status as a major shareholder.


auto_awesomeAnalysis

A group of institutional investors, including Bpifrance Participations, has reduced its beneficial ownership in DBV Technologies S.A. to below the 5% threshold, triggering a final Schedule 13D amendment. This signifies a strategic reduction in their stake and an exit from active 13D reporting, which can be interpreted as a decreased conviction or a rebalancing of their investment portfolio in the company.

At the time of this filing, DBVT was trading at $17.99 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $704.9M. The 52-week trading range was $3.30 to $26.19. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed DBVT - Latest Insights

DBVT
Mar 26, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
8
DBVT
Mar 26, 2026, 5:18 PM EDT
Filing Type: 10-K
Importance Score:
9
DBVT
Mar 02, 2026, 7:54 AM EST
Filing Type: 8-K
Importance Score:
8
DBVT
Jan 16, 2026, 8:29 PM EST
Filing Type: 8-K
Importance Score:
9
DBVT
Jan 14, 2026, 5:36 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
DBVT
Jan 07, 2026, 4:01 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
DBVT
Jan 05, 2026, 4:04 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7